Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$0.2715 -5.07%
Market Cap
$19.7M
Price Target
Refer to Report
Volume
2.1M
52wk Range
$0.217 - $1.74
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.